## Introduction
Exemptia 40mg/0.8ml Injection is a prescription medication manufactured by Zydus Cadila containing the active ingredient Adalimumab. It is primarily used in the treatment of conditions such as Ankylosing spondylitis, Rheumatoid arthritis, Psoriasis, Ulcerative colitis, and Crohn’s disease.
## Uses
Exemptia is commonly prescribed for the following medical conditions:
– Ankylosing spondylitis
– Rheumatoid arthritis
– Psoriasis
– Ulcerative colitis
– Crohn’s disease
## Price
The Maximum Retail Price (MRP) for Exemptia 40mg/0.8ml Injection is ₹25000.
## Dosage
Exemptia is administered as a single injection in a prefilled syringe. The standard dosage is 40mg/0.8ml, as prescribed by your healthcare provider.
## Benefits
Exemptia, containing Adalimumab, belongs to the class of Monoclonal antibodies (mAb) and is categorized as a Disease Modifying Anti-Rheumatoid Drug (DMARD) known as Biologics. It helps in managing symptoms and preventing disease progression in various autoimmune disorders.
## Side Effects
Common side effects of Exemptia may include:
– Headache
– Sinus inflammation
– Rash
– Upper respiratory tract infection
– Injection site reaction
## Active Ingredient
The active ingredient in Exemptia is Adalimumab (40mg/0.8ml), which acts as an immunomodulator and anti-inflammatory agent targeting specific proteins in the body responsible for autoimmune reactions.
## Pharmacological Properties
Adalimumab exerts its therapeutic effects by binding to tumor necrosis factor-alpha (TNF-α), thereby reducing inflammation and modulating the immune response. This mechanism of action leads to the alleviation of symptoms in autoimmune conditions.
## Indications
Exemptia is indicated for use in the treatment of inflammatory and autoimmune conditions, including but not limited to Ankylosing spondylitis, Rheumatoid arthritis, Psoriasis, Ulcerative colitis, and Crohn’s disease.
## Contraindications
Individuals with a known hypersensitivity to Adalimumab or any other components of Exemptia should not use this medication. It is important to inform your healthcare provider of any allergies or pre-existing medical conditions before starting treatment.
## Drug Interactions
Exemptia may interact with certain medications, including other immunosuppressants or biologics. It is essential to inform your doctor about all the medications, supplements, or herbal products you are currently taking to avoid potential drug interactions.
## Patient Counseling
Patients receiving Exemptia should be counseled on the following points:
– The correct administration technique for the prefilled syringe.
– The importance of regular follow-up visits with their healthcare provider.
– Reporting any new or worsening symptoms to the doctor promptly.
## Clinical Evidence
Numerous clinical studies and trials have demonstrated the efficacy and safety of Adalimumab in the management of autoimmune diseases. Patients treated with Exemptia have shown significant improvements in disease activity, quality of life, and functional outcomes.
## Frequently Asked Questions
### Q: Can I self-administer Exemptia injections?
A: No, Exemptia should only be administered by a qualified healthcare professional. Self-administration can lead to incorrect dosing or injection site complications.
### Q: Are there any dietary restrictions while taking Exemptia?
A: There are no specific dietary restrictions associated with Exemptia. However, maintaining a balanced diet and healthy lifestyle can complement the treatment.
### Q: How long does it take to see improvement in symptoms with Exemptia?
A: The time to observe improvements in symptoms may vary among individuals. Some patients may experience relief within a few weeks of starting treatment, while others may require longer duration. It is essential to follow the prescribed treatment plan for optimal outcomes.
### Q: Is Exemptia habit-forming?
A: No, Exemptia is not habit-forming. It is used as a part of the treatment regimen for autoimmune conditions and should be taken as prescribed by the healthcare provider.
### Q: What should I do if I miss a dose of Exemptia?
A: If you miss a dose of Exemptia, contact your healthcare provider for guidance. Do not double the dose to make up for a missed one.
### Q: Can Exemptia be used during pregnancy or while breastfeeding?
A: The use of Exemptia during pregnancy or breastfeeding should be discussed with your doctor. The benefits and risks of treatment need to be carefully evaluated in such cases.
### Q: Are there any specific monitoring requirements while on Exemptia therapy?
A: Regular monitoring of disease activity, laboratory parameters, and potential side effects is essential during Exemptia therapy. Your doctor will guide you on the necessary tests and follow-up visits.
### Q: Can Exemptia be used in pediatric patients?
A: Exemptia may be prescribed for pediatric patients with certain autoimmune conditions. The dosage and administration guidelines for children should be discussed with a pediatric specialist.
## Conclusion
Exemptia 40mg/0.8ml Injection is a valuable treatment option for managing inflammatory and autoimmune conditions effectively. It is essential to adhere to the prescribed dosage, follow healthcare provider instructions, and stay informed about potential side effects or interactions. If you have further questions or concerns about Exemptia, consult your doctor for personalized guidance. Remember, the information provided here is for educational purposes and should not replace professional medical advice.
MRP:
₹25000
Manufacturer:
Zydus Cadila
Salt:
Adalimumab (40mg/0.8ml),
How to UseExemptia 40mg/0.8ml Injection:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects of Exemptia 40mg/0.8ml Injection:
Headache,Sinus inflammation,Rash,Upper respiratory tract infection,Injection site reaction,
Alternate Medicines for Exemptia 40mg/0.8ml Injection:
Mabvinra 40mg Injection,Adfrar Injection,
Prescription Required Status:
Prescription Required
Type of Selection:
1 Injection in 1 prefilled syringe
Chemical Class:
Monoclonal antibody (mAb)
Habit Forming:
No
Therapeutic Class:
ANTI NEOPLASTICS
Action Class:
Disease Modifying Anti-Rheumatoid Drugs (DMARDs)- Biologics
. Please note, this information is for educational purposes only and not intended as medical advice.
